Educational resource · Not a medical device · Infectious diseases review in progress · Does not replace clinical judgement
Review by an infectious diseases specialist in progress · edited by a physician, AI-assisted writing · level of evidence computed from the source type · page as of 29 October 2026 · Methodology
Enterobacteriaceae · Gram-negative
Attention aux céphalosporines de 3e génération : Enterobacter possède une céphalosporinase chromosomique inductible (AmpC). L'utilisation de C3G peut sélectionner des mutants déréprimés résistants en cours de traitement. La SPILF 2015 réserve les carbapénèmes aux situations sans alternative ; le choix définitif se fait sur l'antibiogramme (IDSA/ATS 2016).
Scope: dosing as described in the cited guidelines (French or international context, stated by the source), for adults with normal renal function unless stated on the line. No renal or hepatic, paediatric or pregnancy adjustment is provided systematically. These regimens have not been reviewed by any infectious-disease specialist to date.
| Organ | Tropism | Level of evidence | Sources | Spread route |
|---|---|---|---|---|
| Urinary system / Bladder | High tropism | Evidence B | 1 | not recorded |
| Liver / Bile duct | High tropism | Evidence B | 2 | not recorded |
| Lung | Moderate tropism | Evidence B | 1 | not recorded |
| Colon / Alimentary system | Moderate tropism | Evidence B | 2 | not recorded |
Spread routes recorded: 0 of 4 documented foci A focus without a route is not a focus without spread: the route is simply not recorded.
This page is the text version, generated at build time. The 3D anatomical atlas requires JavaScript.